ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Opinion

Japan is creating access to new treatments for neglected diseases

Preparation for rollout of schistosomiasis drug began while R&D still underway

| Japan
Gathering water in Tanzania: Schistosomiasis is spread by contact with fresh water contaminated with parasitic flatworms. (Photo by UNDP/Phil Kabuje)

Dr. Mandeep Dhaliwal is director of the HIV and health group at the U.N. Development Program. Dr. Osamu Kunii is chief executive of the Tokyo-based Global Health Innovative Technology Fund.

Too often, a new, game-changing medicine emerges from rigorous research and clinical development, secures regulatory approval and then encounters significant implementation delays before reaching the people and communities who need it most.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more